Atrion Corporation (ATRI)

Market Cap	1.01B
Revenue (ttm)	179.17M
Net Income (ttm)	34.25M
Shares Out	1.79M
EPS (ttm)	18.99
PE Ratio	29.75
Forward PE	n/a
Dividend	$8.00 (1.42%)
Ex-Dividend Date	Sep 14, 2022

Volume	5,193
Open	565.00
Previous Close	565.00
Day's Range	559.09 - 579.42
52-Week Range	542.10 - 805.62
Beta	0.24
Analysts	Sell
Price Target	n/a
Earnings Date	Nov 7, 2022

About ATRI

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardi...

• Industry: Health Care Equipment & Supplies
• Founded: 1944
• Employees: 667
• Stock Exchange: NASDAQ
• Ticker Symbol: ATRI

Full Company Profile

Financial Performance

In 2021, Atrion's revenue was $165.01 million, an increase of 11.80% compared to the previous year's $147.59 million. Earnings were $33.06 million, an increase of 2.93%.

Financial Statements

Analyst Forecast

No stock price forecast available yet.

Price Target

n/a

Analyst Consensus: Sell

Stock Forecasts